Background Analysis: US FDA Advisory Committees to Review Janssen’s Esketamine for Treatment-Resistant Depression – FEB 12, 2019 Report
Background Analysis: US FDA Advisory Committees to Review Janssen’s Esketamine for Treatment-Resistant Depression – FEB 12, 2019 Report